Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
CNY 30.51
(-0.46%)
CNY 30.51
(-0.46%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.88 Billion CNY | -45.93% |
| 2022 | 5.32 Billion CNY | -25.81% |
| 2021 | 7.18 Billion CNY | -18.37% |
| 2020 | 8.79 Billion CNY | 5.82% |
| 2019 | 8.31 Billion CNY | 17.26% |
| 2018 | 7.08 Billion CNY | 14.95% |
| 2017 | 6.16 Billion CNY | -1.43% |
| 2016 | 6.25 Billion CNY | 32.92% |
| 2015 | 4.7 Billion CNY | 25.77% |
| 2014 | 3.74 Billion CNY | 13.85% |
| 2013 | 3.28 Billion CNY | 131.36% |
| 2012 | 1.42 Billion CNY | 274.41% |
| 2011 | -814.68 Million CNY | 73.85% |
| 2010 | -3.11 Billion CNY | -574.69% |
| 2009 | 656.28 Million CNY | 24.92% |
| 2008 | 525.38 Million CNY | 36.07% |
| 2007 | 386.1 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -429.37 Million CNY | -114.91% |
| 2024 Q2 | -604.49 Million CNY | -40.78% |
| 2024 Q3 | -681.21 Million CNY | -79.94% |
| 2023 Q4 | 2.88 Billion CNY | 75.69% |
| 2023 Q1 | 2.94 Billion CNY | -44.8% |
| 2023 FY | 2.88 Billion CNY | -45.93% |
| 2023 Q2 | 3.51 Billion CNY | 19.43% |
| 2023 Q3 | 1.63 Billion CNY | -53.32% |
| 2022 FY | 5.32 Billion CNY | -25.81% |
| 2022 Q4 | 5.32 Billion CNY | -28.63% |
| 2022 Q3 | 7.46 Billion CNY | -3.63% |
| 2022 Q2 | 7.74 Billion CNY | 23.32% |
| 2022 Q1 | 6.28 Billion CNY | -12.53% |
| 2021 Q1 | 8.49 Billion CNY | -3.38% |
| 2021 Q3 | 7.64 Billion CNY | 3.81% |
| 2021 Q4 | 7.18 Billion CNY | -6.02% |
| 2021 Q2 | 7.36 Billion CNY | -13.41% |
| 2021 FY | 7.18 Billion CNY | -18.37% |
| 2020 Q2 | 8.85 Billion CNY | 4.92% |
| 2020 Q4 | 8.79 Billion CNY | -0.4% |
| 2020 FY | 8.79 Billion CNY | 5.82% |
| 2020 Q3 | 8.83 Billion CNY | -0.21% |
| 2020 Q1 | 8.43 Billion CNY | 1.48% |
| 2019 Q2 | 7.73 Billion CNY | 8.26% |
| 2019 FY | 8.31 Billion CNY | 17.26% |
| 2019 Q1 | 7.14 Billion CNY | 0.75% |
| 2019 Q4 | 8.31 Billion CNY | -1.13% |
| 2019 Q3 | 8.4 Billion CNY | 8.73% |
| 2018 Q3 | 5.64 Billion CNY | -15.28% |
| 2018 Q4 | 7.08 Billion CNY | 25.56% |
| 2018 Q1 | 5.67 Billion CNY | -7.97% |
| 2018 Q2 | 6.66 Billion CNY | 17.42% |
| 2018 FY | 7.08 Billion CNY | 14.95% |
| 2017 Q2 | 5.63 Billion CNY | -7.92% |
| 2017 FY | 6.16 Billion CNY | -1.43% |
| 2017 Q4 | 6.16 Billion CNY | -5.18% |
| 2017 Q3 | 6.5 Billion CNY | 15.39% |
| 2017 Q1 | 6.12 Billion CNY | -2.16% |
| 2016 Q3 | 5.01 Billion CNY | -9.48% |
| 2016 Q4 | 6.25 Billion CNY | 24.82% |
| 2016 Q2 | 5.53 Billion CNY | -4.94% |
| 2016 FY | 6.25 Billion CNY | 32.92% |
| 2016 Q1 | 5.82 Billion CNY | 23.75% |
| 2015 Q1 | 3.43 Billion CNY | -8.33% |
| 2015 FY | 4.7 Billion CNY | 25.77% |
| 2015 Q3 | 2.82 Billion CNY | -20.87% |
| 2015 Q4 | 4.7 Billion CNY | 66.52% |
| 2015 Q2 | 3.57 Billion CNY | 4.12% |
| 2014 Q4 | 3.74 Billion CNY | -19.18% |
| 2014 Q3 | 4.63 Billion CNY | -0.1% |
| 2014 Q2 | 4.63 Billion CNY | 13.45% |
| 2014 FY | 3.74 Billion CNY | 13.85% |
| 2014 Q1 | 4.08 Billion CNY | 24.3% |
| 2013 FY | 3.28 Billion CNY | 131.36% |
| 2013 Q4 | 3.28 Billion CNY | 15.66% |
| 2013 Q3 | 2.84 Billion CNY | -0.23% |
| 2013 Q2 | 2.84 Billion CNY | 74.08% |
| 2013 Q1 | 1.63 Billion CNY | 15.17% |
| 2012 FY | 1.42 Billion CNY | 274.41% |
| 2012 Q1 | -236.74 Million CNY | 70.94% |
| 2012 Q2 | -473.59 Million CNY | -100.05% |
| 2012 Q3 | 839.11 Million CNY | 277.18% |
| 2012 Q4 | 1.42 Billion CNY | 69.33% |
| 2011 Q1 | -2.34 Billion CNY | 24.78% |
| 2011 FY | -814.68 Million CNY | 73.85% |
| 2011 Q3 | -1.32 Billion CNY | 19.08% |
| 2011 Q4 | -814.68 Million CNY | 38.58% |
| 2011 Q2 | -1.63 Billion CNY | 30.06% |
| 2010 Q2 | -3.83 Billion CNY | -582.06% |
| 2010 Q1 | 796.31 Million CNY | 21.34% |
| 2010 Q3 | -3.55 Billion CNY | 7.28% |
| 2010 Q4 | -3.11 Billion CNY | 12.47% |
| 2010 FY | -3.11 Billion CNY | -574.69% |
| 2009 FY | 656.28 Million CNY | 24.92% |
| 2009 Q4 | 656.28 Million CNY | 0.0% |
| 2008 FY | 525.38 Million CNY | 36.07% |
| 2007 FY | 386.1 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 935.92 Million CNY | -207.772% |
| Zhejiang Zhenyuan Share Co., Ltd. | -320.75 Million CNY | 998.034% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 580.71 Million CNY | -396.03% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 520.61 Million CNY | -453.292% |
| Yifan Pharmaceutical Co., Ltd. | 1.29 Billion CNY | -122.122% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | -129.14 Million CNY | 2330.524% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -562.43 Million CNY | 612.15% |
| Boai NKY Medical Holdings Ltd. | -230.36 Million CNY | 1350.409% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | -1.1 Billion CNY | 359.756% |